RMS Medical Products Announces Rebranding to KORU Medical Systems
23 Octubre 2019 - 7:30AM
Business Wire
New Ticker Symbol
“KRMD”
Repro Med Systems, Inc. (NASDAQ: REPR) (“the Company”)
today announced a new dba name, KORU Medical Systems, which the
Company will begin using in place of RMS Medical Products on
October 24, 2019. Reflecting this change, the Company’s common
stock will commence trading under the new ticker symbol “KRMD” on
the NASDAQ effective October 24, 2019.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20191023005154/en/
The Company announced the rebranding on the eve of this year’s
Immunoglobulin National Society Conference (IgNS 2019) in Las
Vegas, Nevada, a unique, multi-disciplinary gathering of nurses,
pharmacists, physicians, and Ig industry leaders. The Company’s
management team and board of directors will be attending IgNS
2019.
“Our decision to rebrand the Company reflects the great strides
we have made in evolving our corporate culture, mission, and
philosophy to a more patient-centric focus,” said Don Pettigrew,
President and CEO.
“The rebranding is inspired by the koru, a widely recognized
symbol of a spiral-shaped, unfurling fern that represents new life
and new beginnings,” said Mr. Pettigrew. “KORU Medical Systems'
focus on providing patients’ new beginnings with our at-home
infusion systems is at the heart of our brand.”
On October 24, 2019 the Company’s email address will change to
the domain @korumedical.com and its home page will become
www.korumedical.com.
The Committee on Uniform Securities Identification Procedures
(CUSIP) number assigned to the Company's common stock will remain
the same. The dba name change will not affect the rights of the
Company's stockholders. The Company’s corporate name, Repro Med
Systems, Inc., will not change as a result of the dba name change
at this time.
About the Company
The Company develops, manufactures and commercializes innovative
and easy-to-use specialty infusion solutions that improve quality
of life for patients around the world. The FREEDOM Syringe Infusion
System currently includes the FREEDOM60® and FreedomEdge® Syringe
Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo
Subcutaneous Safety Needle Sets™. These devices are used for
infusions administered in the home and alternate care settings.
Forward-Looking
Statements
The statements contained herein include prospects, statements of
future expectations and other forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995
that are based on management's current views and assumptions and
involve known and unknown risks and uncertainties, identified by
words such as “will.” Actual results, performance or events may
differ materially from those expressed or implied in such
forward-looking statements. Factors that may cause actual results
to differ materially from current expectations and other risks are
discussed in the Company’s filings with the U.S. Securities and
Exchange Commission, including its Annual Report on Form 10-K,
which filings are available from the SEC and the Company’s website.
The Company undertakes no obligation to update any forward-looking
statements.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191023005154/en/
The Equity Group Inc. Devin Sullivan Senior Vice
President 212-836-9608 dsullivan@equityny.com
Kalle Ahl, CFA Vice President 212-836-9614 kahl@equityny.com
Repro Med Systems (NASDAQ:REPR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Repro Med Systems (NASDAQ:REPR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024